Acrx financials
WebCurrent and historical debt to equity ratio values for AcelRx Pharmaceuticals (ACRX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. AcelRx Pharmaceuticals debt/equity for the three months ending December 31, 2024 was 0.00. WebMar 24, 2024 · Get the detailed income statement for AcelRx Pharmaceuticals, Inc. (ACRX). Up to 10 years of financial statements. Quarterly or annual. View as % YoY growth or as …
Acrx financials
Did you know?
WebJul 15, 2024 · AcelRx Pharmaceuticals, Inc. Common Stock (ACRX) Financials Nasdaq Financials: ACRX Edit my quotes AcelRx Pharmaceuticals, Inc. Common Stock (ACRX) … WebACRX AcelRx Pharmaceuticals Inc. Financial Statements - WSJ AcelRx Pharmaceuticals Inc. ACRX (U.S.: Nasdaq) View All companies AT CLOSE 4:00 PM EST 02/23/23 $1.44 …
WebApr 10, 2024 · ACRX’s price/sales is 2.69. Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues. Web1 day ago · Find out why ACRX stock is a Hold. ... This will surely be reported by management in the quarterly financials at the latest. ACRX submits the Niyad application by the end of 2q2024 at the latest ...
WebACRX AcelRx Pharmaceuticals Inc. Annual Cash Flow - WSJ Subscribe Sign In AcelRx Pharmaceuticals Inc. ACRX (U.S.: Nasdaq) View All companies REAL TIME 2:57 PM … WebGet the latest AcelRx Pharmaceuticals Inc (ACRX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …
WebApr 6, 2024 · AcelRx Pharmaceuticals (ACRX) Reports Q4 Loss, Lags Revenue Estimates AcelRx Pharmaceuticals (ACRX) delivered earnings and revenue surprises of -900% …
WebAcelRx Pharmaceuticals, Inc. (ACRX) Stock Price, News, Quote & History - Yahoo Finance My Portfolio Personal Finance Industries U.S. markets closed S&P Futures 4,133.25 … differentiate between save and save asWebFind real-time ACRX - AcelRx Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. ACRX - AcelRx Pharmaceuticals Inc Stock quote - … format salaryWeb/PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company, today announced that it will release second quarter financial... ACRX : 0.2400 (+5.08%) AcelRx Pharmaceuticals (ACRX) Reports Q1 Loss, Lags Revenue Estimates Zacks - Mon May 16, 7:45AM CDT formats afficheWebACRX Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds AcelRx Pharmaceuticals, Inc. Investors of Class Action and Lead Plaintiff Deadline: August 9, 2024. Business Wire. AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. formats aiWebFeb 24, 2024 · Income Statement (Annual) Financials in millions USD. Fiscal year is January - December. Source: Financials are provided by Nasdaq Data Link and sourced … format sains spm 2021WebACRX Finanicals Stock Screener Earnings Calendar Sectors Nasdaq ACRX U.S.: Nasdaq AcelRx Pharmaceuticals Inc. Watch list Create ACRX Alert Open Last Updated: Sep 22, 2024 3:01 p.m. EDT... format safes warrantyWebNov 15, 2024 · AcelRx had $48.7 million of cash and short-term investments as of September 30, 2024 DSUVIA® achieved 646 formulary approvals as of October 31, … formats a3